Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 174413011000036113 | beractant | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 174414011000036110 | beractant (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| beractant | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| beractant | has intended active ingredient | True | beractant | Inferred relationship | Some | 1 |
| beractant 200 mg/8 mL intratracheal suspension, vial | has intended active ingredient | True | beractant | Inferred relationship | Some | 1602342836 |
| beractant 200 mg/8 mL intratracheal suspension, vial | has Australian BoSS | True | beractant | Inferred relationship | Some | 1602342836 |
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | has intended active ingredient | True | beractant | Inferred relationship | Some | 1614506900 |
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | has Australian BoSS | True | beractant | Inferred relationship | Some | 1614506900 |
This concept is not in any reference sets
FHIR